https://anamingorance.com/home daily 0.75 2022-05-07 https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1546197426766-1CJGM8WIHC9R5B6FA0KZ/Ana+Mingorance+PhD Home https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1546197988356-GZEDA4RMPNN7KDE29WCJ/Dracaena+Consulting Home https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1573730655153-9Y38F63ZYGD1509GX466/Screen+Shot+2019-11-14+at+12.23.47.png Home https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1546201938030-CKSXIGX21RQ2VDC3RJAF/Picture1.png Home https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1546206635784-CWJYQBDRSQ3NZ61CQ2V5/image.png Home - WHAT MARIHUANA TEACHES US ABOUT DRUG DISCOVERY December 16, 2016 https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1546206639744-Z0A7BADHHVO3624WV9W2/image.png Home - 2016 NUMBERS: CNS ORPHAN DRUGS GROWING January 5, 2017 https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1546206643270-5FBJD3JPBBC1VOP1F7RS/image.png Home - EVEROLIMUS, AND HOW RARE DISEASES ARE REVIVING THE FIELD OF EPILEPSY https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1546206647481-02DWHUG8L0HF9RBRHPAT/image.png Home - 7 LESSONS FROM THE WORLD ORPHAN DRUG CONGRESS https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1546206848771-AZAS46WZFF7BE7DEVVTE/medicine.jpg Home - GENES VS SYNDROMES AT THE INTERNATIONAL EPILEPSY CONGRESS IN BARCELONA https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1546206927843-WMN82Q0YZXR023VJZ1JR/rubik.jpg Home - BIG GENE, SMALL VIRUS https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1546207013650-MM01NYZ7PQ2ED4ZGQTWZ/medicine+green.jpg Home - WHAT YOU SHOULD KNOW ABOUT PATIENT DATA AFTER MAY 2018 https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1546207052318-ZEAKRU3L03FJ8RUSWPPL/AES+2018.jpg Home - TOP 5 INSIGHTS FROM THE AMERICAN EPILEPSY SOCIETY MEETING (2018) https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1546207296367-TMQS4PZKUE93EEK21IX8/cdd+forum.png Home - MAIN LESSONS FROM THE 2018 CDKL5 FORUM https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1546206058430-LHOCY5LXGHMPDQT6TNIR/Screen+Shot+2018-12-30+at+22.40.48.png Home https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1546202418723-U8V44VZK253E7HL9DRAO/Picture1.png Home https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1546199158013-76SD0D6PR7XFLVH5A0UB/20171023_162854.jpg Home https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1546199158138-GRPHD7CLE4SOCFODAZ9S/CBD%2Bana%2Bhablando.jpg Home https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1546199160776-QRQZZ79EO0DZ3AWAQIEF/IMG_1625.JPG Home https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1546199159279-U64MQHHT9FG998B1AS19/L1140187.jpg Home https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1546199160507-U7A69DLFY0QZAQ99U78O/NH20170330-108-LR.jpg Home https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1546191193248-A8DZIRNI7D74M4FD8NOL/Side+profile+BW.jpg Home https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1546195373142-WYUEGMDBZQRLEXQ5CKII/impatient.png Home https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1574069437222-VV0VL1BBGQ19X7UQY482/dravet2.jpg Home https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1574069678022-CIZB00MSSMT7C8QCOSKY/Dracaena%2Bconsulting2.jpg Home https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1574070013885-BAXDALRLXMDB4CPL3OG7/speaking+4.png Home https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1574070458430-PXCIY5IYE1QM221KFMC3/strategy2.jpg Home https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1574071035116-MUO8FBIZ4HXXVU7E94BA/rare%252Bdisease%252Bpatients%252B3.jpg Home https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1574071091534-E8RYFHHBI9PAYX8IA997/drug%2Bhunters5.jpg Home https://anamingorance.com/home-sofia daily 1.0 2026-01-08 https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/b36b3cd3-3191-43e8-be29-d8b66f736409/Ana+Mingorance Welcome - Hi, I’m Ana. I’m on a mission to make more diseases treatable, and to make the development of medicines sustainable. https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/2f3a3a12-6439-4fb3-8423-d9b5ca666ea4/Picture2.png Welcome - Managing Director and Lead Consultant, Dracaena Consulting Boutique consultancy specialized in therapy development for epilepsy and rare neurodevelopmental disorders. https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/bb55c1de-4fcd-428a-928c-e2307942e47c/Picture4.png Welcome - Scientific Advisor, Dravet Syndrome European Federation Non-profit organization, federation of European patient organizations active in the field of Dravet Syndrome and driven by patients and patients’ caregivers. https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/b37cfcd0-a007-4ff9-b56f-716841982f5d/Screen+Shot+2024-03-18+at+8.07.11+PM.png Welcome - Supporting therapeutic program development by the DHPS Foundation Non-profit foundation looking for treatments for an ultra-rare neurodevelopmental disorder caused by mutations in the DHPS gene. https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/9276a3e5-70e6-415a-bfa9-420b285cd5aa/Picture3.png Welcome - Chief Development Officer, Loulou Foundation Non-profit foundation dedicated to advancing research into the understanding and development of therapeutics for CDKL5 deficiency disorder. https://images.squarespace-cdn.com/content/v1/58d00f106b8f5b01c8e73f52/1491858366054-VN3632LUL8YNY0SH4RCQ/color-3.png Welcome https://images.squarespace-cdn.com/content/v1/5c28f86df407b4e206c65482/1656667702576-H3IR1ZKCXWKV5ZYJGVNU/Screen+Shot+2022-07-01+at+11.28.00+AM.png Welcome